ASX
LCT 0.024   Last updated 6.01 pm
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

The following fact sheet provides a summary of our current business and research pipeline.

Home

Cell therapy for neurodegenerative diseases

Living Cell Technologies Limited (LCT) is an Australasian biotechnology company improving the wellbeing of people with serious diseases worldwide by discovering, developing and commercialising regenerative treatments which restore function using naturally occurring cells.

 

Our lead product, NTCELL®, is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. After transplantation NTCELL functions as a biological factory, producing factors to promote new central nervous system growth and repair disease-induced nerve degeneration.

 

A Phase IIb trial of NTCELL for Parkinson's disease is currently underway. It aims to confirm the most effective dose of NTCELL, define any placebo component of the response and further identify the initial target Parkinson’s disease patient sub group. At 26 weeks post treatment, the trial was unblinded. It showed that NTCELL was safe and well tolerated but at this stage, did not meet the primary efficacy endpoint. Patients will be assessed again at 52 weeks post implant and we are waiting for these follow up results. 

 

In addition to Parkinson’s disease, NTCELL has the potential to be used in a number of other central nervous system indications, including Huntington’s, Alzheimer’s and motor neurone diseases including amyotrophic lateral sclerosis (ALS).

 

LCT’s proprietary encapsulation technology, IMMUPEL™, allows cell therapies to be used without the need for co-treatment with drugs that suppress the immune system.

 

LCT is listed on the Australian (ASX: LCT) and US (OTCQX: LVCLY) stock exchanges and is incorporated in Australia, with operations based in New Zealand.

— 15 November 2017

Results of voting at the AGM

Results of voting at the 2017 AGM

Read More Read Less

— 15 November 2017

Presentation to AGM - Dr Ken Taylor, CEO

Presentation to Annual General Meeting by Dr Ken Taylor, CEO

Read More Read Less
Load More

— 16 September 2017

Sir Richard Faull on RNZ National

On Saturday Morning on RNZ National, LCT Scientific Advisor Sir Richard Faull and businessman Bernie Crosby talk to Kim Hill about the work of the University of Auckland Centre for Brain Research and finding a cure for Parkinson's disease.

Read More Read Less

— 13 June 2017

Pig brain cells implanted into brains of people with Parkinson’s

Would you have pig cells implanted in your brain? Some people with Parkinson’s disease have, in the hope it will stop their disease progressing. The approach is still in the early stages of testing, but initial results from four people look promising, with all showing some improvement 18 months after surgery. Living Cell Technologies, based in Auckland, New Zealand, has been developing a treatment that uses cells from the choroid plexus in pigs. This brain structure makes a cocktail of growth factors and signalling molecules known to help keep nerve cells healthy.

Read More Read Less
Load More
icon
— 15 November 2017

LCT Annual General Meeting. To be held at Top Of The Town, Pullman Auckland, Cnr Princes St & Waterloo Quadrant, Auckland City 1143 at 2.00pm

Load More
Announcements

— 15 November 2017

Results of voting at the AGM

Results of voting at the 2017 AGM

Read More Read Less

— 15 November 2017

Presentation to AGM - Dr Ken Taylor, CEO

Presentation to Annual General Meeting by Dr Ken Taylor, CEO

Read More Read Less
Load More
LCT in the News

— 16 September 2017

Sir Richard Faull on RNZ National

On Saturday Morning on RNZ National, LCT Scientific Advisor Sir Richard Faull and businessman Bernie Crosby talk to Kim Hill about the work of the University of Auckland Centre for Brain Research and finding a cure for Parkinson's disease.

Read More Read Less

— 13 June 2017

Pig brain cells implanted into brains of people with Parkinson’s

Would you have pig cells implanted in your brain? Some people with Parkinson’s disease have, in the hope it will stop their disease progressing. The approach is still in the early stages of testing, but initial results from four people look promising, with all showing some improvement 18 months after surgery. Living Cell Technologies, based in Auckland, New Zealand, has been developing a treatment that uses cells from the choroid plexus in pigs. This brain structure makes a cocktail of growth factors and signalling molecules known to help keep nerve cells healthy.

Read More Read Less
Load More
Events
icon
— 15 November 2017

LCT Annual General Meeting. To be held at Top Of The Town, Pullman Auckland, Cnr Princes St & Waterloo Quadrant, Auckland City 1143 at 2.00pm

Load More
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.